| 摘要 |
<p>The invention provides HIV protease inhibitors which are potential drugs for HIV infected patients or cells. Preferably, peptides are provided that have an amino alcohol core that mimics a Phe-Pro and/or Leu-Pro binding site for the protease. The core is preferably ringed by at least three amino acids. In one form, an N-terminal cap is positioned adjacent to an Asn residue.</p> |
